Briefing Detail Page
Pathways to Universal Coverage: Payment Reform Strategies for Containing Costs
Friday, March 20, 2009
Provider payment policy is a hot topic again with the Medicare physician payment system due for a fix and value-based payment and other cost containment/quality schemes on the table as part of the health reform debate. This briefing sponsored by the Alliance and The Commonwealth Fund examined cost containment options in payment reform.
Stuart Guterman, assistant vice president of The Commonwealth Fund's Program on Medicare's Future, and former director of the Office of Research, Development and Information at the Centers for Medicare and Medicaid Services.
Nancy Nielsen, president of the American Medical Association. Prior to her involvement with the AMA, Dr. Nielsen was speaker of the Medical Society of the State of New York House of Delegates and chief medical officer of a large regional health plan in the Buffalo area.
Bruce Hamory, executive vice president and system chief medical officer emeritus at Geisinger Health System. His current responsibilities include Geisinger's research institutes, and medical and postgraduate education programs.
Robert Berenson, senior fellow at the Urban Institute and former director of Medicare payment policy and private health plan contracting in the Centers for Medicare and Medicaid Services.
Ed Howard and Karen Davis of The Commonwealth Fund moderated.
Ed Howard, Alliance for Health Reform, Moderator
Karen Davis, The Commonwealth Fund, Moderator
Stuart Guterman, The Commonwealth Fund, Speaker
Nancy Nielsen, American Medical Association, Speaker
Bruce Hamory, Geisinger Health System, Speaker
Robert Berenson, Urban Institute, Speaker
(Click on the camera icon to see a video of the speaker's presentation.)
|Transcript, Event Summary and/or Webcast and Podcast|
Transcript: Pathways to Universal Coverage: Payment Reform Strategies for Containing Costs (Adobe Acrobat PDF), 3/20/2009
Event Summary: Pathways to Universal Coverage: Payment Reform Strategies for Containing Costs (Word Document), 3/20/2009
Full Webcast/Podcast: Pathways to Universal Coverage: Payment Reform Strategies for Containing Costs
|The transcript, full webcast and podcast for this briefing, as well as videos of individual speakers' presentations, are provided by Kaiser Family Foundation.
Guterman Presentation (PowerPoint), 3/20/2009
Berenson Presentation (PowerPoint), 3/20/2009
Hamory Presentation (PowerPoint), 3/20/2009
Nielsen Presentation (PowerPoint), 3/20/2009
(If you want to download one or more slides from these presentations, contact us at info@allhealth or click here for instructions.)
Policy Points: The Path to a High Performance U.S. Health System (Adobe Acrobat PDF), The Commonwealth Fund, 3/20/2009
Reforming Provider Payment: Essential Building Block for Health Reform (Adobe Acrobat PDF), The Commonwealth Fund, 3/20/2009
Sourcelist (Adobe Acrobat PDF), , 3/20/2009
Speaker Biographies (Adobe Acrobat PDF), , 3/20/2009
Pathways to Universal Coverage: Payment Reform Strategies for Containing Costs (Word Document), , 3/20/2009
|Offsite Materials (briefing documents saved on other websites)|
Health Care Opinion Leaders’ Views on Payment System Reform, The Commonwealth Fund, 11/3/2008
The Path to a High Performance U.S. Health System, The Commonwealth Fund, 2/19/2009
Getting What We Pay For: Innovations Lacking in Provider Payment Reform for Chronic Disease, Center for Studying Health System Change, 6/30/2008
Taking Stock of Pay-For-Performance: A Candid Assessment From The Front Lines, Health Affairs, 3/1/2009
Ending the Physician Payment Crisis: Another Reason for Major Medicare Reform, The Heritage Foundation, 5/20/2008
Healthcare Payment Reform: From Principle to Action, Healthcare Financial Management Association, 6/23/2008
Healthcare Payment Reform: Creating conditions for More Efficient Health Delivery (Adobe Acrobat PDF),Health Industry Forum, 4/10/2008
Testimony of Nancy Nielsen, House Committee on Ways and Means, 9/11/2008
Physician Services Payment System (Adobe Acrobat PDF),MedPAC, 10/8/2008
Report to the Congress: Fact sheet (Adobe Acrobat PDF),MedPAC, 2/27/2009
Health Care Reform Requires Accountable Care Systems, Journal of the American Medical Association, 7/2/2008
Collective Accountability for Medical Care – Toward Bundled Medicare Payments, New England Journal of Medicine, 7/3/2008
Beyond Pay for Performance – Emerging Models of Provider-Payment Reform, New England Journal of Medicine, 9/18/2008
From Volume to Value: Transforming Health Care Payment and Delivery Systems to Improve Quality , Network for Regional Healthcare Improvement, 7/31/2008
Testimony of Robert Berenson “Aligning Incentives: The Case for Delivery System Reform”, Senate Finance Committee, 9/16/2008
Stuart Guterman, assistant vice president of The Commonwealth Fund, discussed provider payment recommendations in the fund's recent report, "The Path to a High Performance U.S. Health System," at the March 20 briefing, cosponsored by the fund. (12 min.)
Toolkit on Connection Between Health and Housing
A new Alliance toolkit, “The Connection between Health and Housing: The Evidence and Policy Landscape,” provides a detailed look into federal, state and local initiatives, as well as cost implications for health and housing programs.
Attempts to tie health and housing policy are gaining momentum, amid evidence that housing, a social determinant of health, is an important factor in the health status of various populations. More than 610,000 people experience homelessness in the U.S., and over 250,000 individuals within that population have a severe mental illness or a chronic substance use disorder, according to the Department of Housing and Urban Development.
Toolkit on Biosimilars
The Alliance for Health Reform has released a new toolkit, “Biosimilars: Unpacking Complex Issues.”
The Affordable Care Act created an expedited licensure pathway for biosimilars, and, in March 2015, the U.S. approved the first biosimilar, leaving policy makers, regulators, providers and stakeholders to grapple with regulatory and financial questions.
Biosimilars are similar – but not identical – to biologic drugs, and cost less. Unlike traditional pharmaceuticals, biologic drugs are derived from living organisms and tissues, making them more complex and expensive to produce.